Rockwell Medical Inc Drug Patent Portfolio
Rockwell Medical Inc owns 2 orange book drugs protected by 4 US patents Given below is the list of Rockwell Medical Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7816404 | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions | 17 Apr, 2029 | Active |
| US7857977 | Packaging of ferric pyrophosphate for dialysis | 08 Sep, 2027 | Active |
| US6689275 | Method and pharmaceutical composition for replacing iron losses in dialysis patients | 31 Dec, 2016 | Expired |
| US6779468 | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients | 31 Dec, 2016 | Expired |
Latest Legal Activities on Rockwell Medical Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rockwell Medical Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 19 May, 2022 | US7857977 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 22 Mar, 2022 | US7816404 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 22 Mar, 2022 | US7816404 |
|
Email Notification
Critical
| 16 Jan, 2019 | US7816404 |
|
Email Notification
Critical
| 16 Jan, 2019 | US7816404 |
|
Correspondence Address Change
Critical
| 15 Jan, 2019 | US7816404 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 15 Jan, 2019 | US7816404 |
|
Correspondence Address Change
Critical
| 15 Jan, 2019 | US7816404 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 15 Jan, 2019 | US7816404 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 14 Jun, 2018 | US7857977 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Apr, 2018 | US7816404 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Apr, 2018 | US7816404 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Jan, 2014 | US7816404 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Jan, 2014 | US7857977 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Jan, 2014 | US7816404 |
Rockwell Medical Inc's Drug Patent Litigations
Rockwell Medical Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Feb 13, 2009, against patent number US7857977. The petitioner , challenged the validity of this patent, with Lori L. Wash as the respondent. Click below to track the latest information on how companies are challenging Rockwell Medical Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US7857977 | February, 2009 |
Decision
(23 Aug, 2010)
| Lori L. Wash | |
Rockwell Medical Inc's Family Patents
Rockwell Medical Inc Drug List
Given below is the complete list of Rockwell Medical Inc's drugs and the patents protecting them.
1. Triferic
Triferic is protected by 4 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7816404 | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
17 Apr, 2029
(4 years from now)
| Active |
| US7857977 | Packaging of ferric pyrophosphate for dialysis |
08 Sep, 2027
(2 years from now)
| Active |
| US6689275 | Method and pharmaceutical composition for replacing iron losses in dialysis patients |
31 Dec, 2016
(7 years ago)
| Expired |
| US6779468 | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
31 Dec, 2016
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Triferic's drug page
2. Triferic Avnu
Triferic Avnu is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7816404 | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
17 Apr, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Triferic Avnu's drug page